𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytology screening for cervical cancer

✍ Scribed by Cecilia Sepulveda; Anthony B. Miller

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
34 KB
Volume
111
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

DNA methylation analysis in liquid-based
DNA methylation analysis in liquid-based cytology for cervical cancer screening
✍ Sophia Apostolidou; Richard Hadwin; Matthew Burnell; Allison Jones; Donna Baff; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 149 KB

## Abstract Cervical cancer is the second most common type of cancer in women worldwide. Preinvasive disease can be detected by cervical cytology. All currently available cytology technologies rely on the visual analysis of exfoliated cells from the uterine cervix. Improvement of conventional cytol

Randomized controlled trial of human pap
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)
✍ Marie-HΓ©lΓ¨ne Mayrand; Eliane Duarte-Franco; FranΓ§ois CoutlΓ©e; Isabel Rodrigues; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 403 KB πŸ‘ 1 views

## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare

Human papillomavirus testing and cervica
Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: Comparison of sensitivity, specificity, and frequency of referral
✍ Lisa M. Moy; Fang-Hui Zhao; Long-Yu Li; Jun-Fei Ma; Qing-Ming Zhang; Feng Chen; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 431 KB πŸ‘ 2 views

## Abstract The causal relationship between persistent high‐risk human papillomavirus infection and cervical cancer is widely accepted. HR‐HPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HR‐HPV DNA) of